收费全文 | 195138篇 |
免费 | 18620篇 |
国内免费 | 11499篇 |
耳鼻咽喉 | 1603篇 |
儿科学 | 2326篇 |
妇产科学 | 2190篇 |
基础医学 | 28037篇 |
口腔科学 | 3537篇 |
临床医学 | 23639篇 |
内科学 | 28098篇 |
皮肤病学 | 2280篇 |
神经病学 | 9783篇 |
特种医学 | 7304篇 |
外国民族医学 | 98篇 |
外科学 | 19463篇 |
综合类 | 30702篇 |
现状与发展 | 35篇 |
一般理论 | 14篇 |
预防医学 | 13359篇 |
眼科学 | 4934篇 |
药学 | 21706篇 |
158篇 | |
中国医学 | 10360篇 |
肿瘤学 | 15631篇 |
2024年 | 706篇 |
2023年 | 2921篇 |
2022年 | 7672篇 |
2021年 | 9832篇 |
2020年 | 7014篇 |
2019年 | 6341篇 |
2018年 | 6717篇 |
2017年 | 6081篇 |
2016年 | 5983篇 |
2015年 | 8658篇 |
2014年 | 10771篇 |
2013年 | 10283篇 |
2012年 | 14940篇 |
2011年 | 15666篇 |
2010年 | 10714篇 |
2009年 | 8714篇 |
2008年 | 10731篇 |
2007年 | 10603篇 |
2006年 | 9707篇 |
2005年 | 8791篇 |
2004年 | 6728篇 |
2003年 | 6458篇 |
2002年 | 5551篇 |
2001年 | 4584篇 |
2000年 | 4116篇 |
1999年 | 3725篇 |
1998年 | 2277篇 |
1997年 | 2441篇 |
1996年 | 1777篇 |
1995年 | 1620篇 |
1994年 | 1433篇 |
1993年 | 1003篇 |
1992年 | 1293篇 |
1991年 | 1125篇 |
1990年 | 1001篇 |
1989年 | 908篇 |
1988年 | 795篇 |
1987年 | 689篇 |
1986年 | 632篇 |
1985年 | 512篇 |
1984年 | 420篇 |
1983年 | 352篇 |
1982年 | 290篇 |
1981年 | 253篇 |
1980年 | 209篇 |
1979年 | 219篇 |
1978年 | 203篇 |
1977年 | 215篇 |
1976年 | 195篇 |
1974年 | 164篇 |
Background
The intravenous thrombolysis (IVT) with recombinant tissue plasminogen activator (rt-PA) therapy is safe and efficient during the treatment of acute ischemic stroke. Nonetheless, the different outcomes among various stroke subgroups have limited data with regard to the safety and efficacy of cryptogenic stroke (CS). The present study compared the safety and efficacy when IVT with rt-PA was used for the treatment of CS and the other stroke subtypes.Methods
This study classified the IVT with rt-PA patients within 4.5 hours after stroke onset, based on the trial of ORG 10172 in acute stroke treatment criteria in terms of diagnostic evaluation. The data were obtained from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China database, a large multicenter prospective registry. A multivariable logistic regression model was employed to compare the differences between the subtypes in symptomatic intracerebral hemorrhage (sICH) within 7 days and studied the mortality and the outcome during 90 days.Results
In total, 1118 patients were recruited; of these, 131 (11.7%) suffered from CS and 987 (88.3%) with the other etiology. In the CS group, patients were younger than those in the other etiology groups (P < .001). Moreover, it had a lower prevalence of previous stroke (P?=?.0117), receiving antiplatelet drug in 24 hours prior to thrombolysis (P?=?.0017), and functional independence (mRS > 1 before stroke, P?=?.003). The CS group had lower blood pressure (systolic blood pressure P?=?.0001; diastolic blood pressure; P?=?.0212) before thrombolysis, atrial fibrillation (P < .001), and diabetes mellitus (P?=?.0005). Transient ischemic attack, hypertension, hyperlipidemia, blood glucose, receiving anticoagulants in 24 hours prior to thrombolysis, and standard dosage of rt-PA were equally distributed in both groups. After the adjustment of confounders between the CS and the other subgroups, no obvious differences were observed in sICH rate and mortality (P > .05) The CS patients exhibited excellent recovery (mRS, 0-1; 63.78%) and functional independence (mRS, 0-2; 74.8%) than the large artery atherosclerosis patients.Conclusions
IVT with rt-PA is a safe and effective method for the treatment of CS patients. 相似文献The metabolism of the pyrethroids deltamethrin (DLM), cis-permethrin (CPM) and trans-permethrin (TPM) was studied in human expressed cytochrome P450 (CYP) and carboxylesterase (CES) enzymes.
DLM, CPM and TPM were metabolised by human CYP2B6 and CYP2C19, with the highest apparent intrinsic clearance (CLint) values for pyrethroid metabolism being observed with CYP2C19. Other CYP enzymes contributing to the metabolism of one or more of the three pyrethroids were CYP1A2, CYP2C8, CYP2C9*1, CYP2D6*1, CYP3A4 and CYP3A5. None of the pyrethroids were metabolised by CYP2A6, CYP2E1, CYP3A7 or CYP4A11.
DLM, CPM and TPM were metabolised by both human CES1 and CES2 enzymes.
Apparent CLint values for pyrethroid metabolism by CYP and CES enzymes were scaled to per gram of adult human liver using abundance values for microsomal CYP enzymes and for CES enzymes in liver microsomes and cytosol. TPM had the highest and CPM the lowest apparent CLint values for total metabolism (CYP and CES enzymes) per gram of adult human liver.
Due to their higher abundance, all three pyrethroids were extensively metabolised by CES enzymes in adult human liver, with CYP enzymes only accounting for 2%, 10% and 1% of total metabolism for DLM, CPM and TPM, respectively.